Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer

Urology

Volumn 57, Issue 6, 2001, Pages 1100-1104

  Potter, Steven R ^a   Horniger, Wolfgang ^b   Tinzl, Martina ^b   Bartsch, Georg ^b   Partin, Alan W ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOCTOR PATIENT RELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CARCINOMA; REGRESSION ANALYSIS; STATISTICAL MODEL; TRANSRECTAL ULTRASONOGRAPHY;

AGE FACTORS; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PALPATION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; STATISTICS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035020819     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)00980-3     Document Type: Article

References (19)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
2. Brawer M.K. Prostate-specific antigen current status . CA Cancer J Clin. 49:1999;264-281.
3. Catalona W.J., Richie J.P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
4. Woolf S.H. Screening for prostate cancer with prostate-specific antigen an examination of the evidence . N Engl J Med. 333:1995;1401-1405.
5. Littrup P.J. Future benefits and cost effectiveness of prostate carcinoma screening. Cancer. 80:1997;1864-1870.
6. Arcangali C.G., Ornstein D.K., Keetch D.W., et al. Prostate-specific antigen as a screening test for prostate cancer. Urol Clin North Am. 24:1997;299-305.
7. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 324:1991;1156-1161.
8. Richie J.P., Catalona W.J., Ahmann F.R., et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 42:1993;365-374.
9. Catalona W.J., Smith D.S., Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination enhancement of specificity with free PSA measurement . JAMA. 277:1997;1452-1455.
10. Ross K.S., Carter H.B., Pearson J.D., et al. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. JAMA. 284:2000;1399-1405.
11. Oesterling J.E., Cooner W.H., Jacobsen S.J., et al. Influence of patient age on the serum PSA concentration an important clinical observation . Urol Clin North Am. 20:1993;671-680.
12. Carter H.B., Pearson J.D., Metter J., et al. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA. 267:1992;2215-2220.
13. Richardson T.D., Oesterling J.E. Age-specific reference ranges for serum prostate-specific antigen. Urol Clin North Am. 24:1997;339-351.
14. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic diseases. JAMA. 279:1998;1542-1547.
15. Benson M.C., Whang I.S., Olsson C.A., et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821.
16. Reissigl A., Horninger W., Fink K., et al. Prostate carcinoma screening in the County of Tyrol, Austria. Cancer. 80:1997;1818-1829.
17. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men establishment of age-specific reference ranges . JAMA. 270:1993;860-864.
18. Cooner W.H., Mosley B.R., Rutherford C.L. Jr, et al. Prostate cancer detection in a clinical urology practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 143:1990;1146-1154.
19. Carlson G.D., Calvanese C.B., Partin A.W. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer results on 4298 cases . Urology. 52:1998;455-461.